Taboola.com vs TripAdvisor
TBLA and TRIP side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How TBLA and TRIP compare
TripAdvisor is the larger company, worth 1.5 times as much as Taboola.com ($850M against $575M).
TripAdvisor grew revenue faster over the last twelve months (3.2% versus 2.5% for Taboola.com).
Taboola.com keeps more of each dollar of sales as profit, with a net margin of 6.8% compared with −19.7% at TripAdvisor.
Taboola.com scores higher on the StockData Score (14 against 5 for TripAdvisor), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | TBLA | TRIP |
|---|---|---|
| Size and price | ||
| Market cap | $575M | $850M |
| Share price | $2.13 | $7.25 |
| Change, 1 year | −48.6% | −53.1% |
| Change, 5 years | −77.4% | −74.9% |
| Beta (5Y) | 1.69 | 1.15 |
| Employees | 2,000 | 2,590 |
| StockData Score | ||
| Total score | 14 (better) | 5 |
| Valuation score | 3 | 3 |
| Growth score | 3 (better) | 1 |
| Performance score | 5 (better) | 0 |
| Health score | 3 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.3× (better) | 0.5× |
| P/B | 0.6× (better) | 2.3× |
| EV/EBITDA | 3.5× | – |
| P/FCF | 3.3× | – |
| FCF yield | 30.4% (better) | −4.0% |
| Fair value | $8.36 | $16.22 |
| Margin of safety | 74.5% (better) | 55.3% |
| Growth | ||
| Revenue growth (TTM) | 2.5% | 3.2% (better) |
| Revenue growth, 5Y average | 10.0% | 25.6% (better) |
| Net income growth (TTM) | 421% (better) | −556% |
| EPS growth (TTM) | – | −578% |
| Profitability | ||
| Gross margin | 31.0% | 91.6% (better) |
| Operating margin | 7.6% (better) | −19.6% |
| Net margin | 6.8% (better) | −19.7% |
| FCF margin | 9.1% (better) | −1.9% |
| Return on equity | 14.3% (better) | −67.3% |
| Return on invested capital | 13.3% (better) | −47.0% |
| Financial health | ||
| Debt / equity | 0.08 (better) | 2.25 |
| Net debt / EBITDA | −0.34 | – |
| Interest coverage | – | −5.8× |
| Current ratio | 1.09 | 1.75 (better) |
| Altman Z-score | 2.14 (better) | 0.93 |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Dividend yield | – | 0.00% |
| Years of dividend growth | – | 0 |
| Buyback yield | 28.7% | – |
| Shareholder yield | 28.7% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 36.6% | 112% |
| Held by insiders | 56.5% | 18.4% |
| Insider net buying, 12 months | −$106M | −$640K (better) |
| Superinvestors holding | – | 2 |
| Short interest, % of float | 7.3% | 38.7% |
Go deeper
- TBLA stock overview
- TBLA income statement
- TBLA valuation and score
- TRIP stock overview
- TRIP income statement
- TRIP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.